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ABSTRACT  
 
This work concerns the identification of the allelic sequences of the DQB1 gene of the human leukocyte antigen 
system conferring susceptibility to the development of insulin-dependent diabetes mellitus (IDDM) in DNA samples 
with no need of PCR amplification.  
Our method is based on the time-resolved analysis of a Förster energy-transfer mechanism that occurs in a dual-
labeled fluorescent probe specific for the base sequence of the allelic variant of interest. Such an oligonucleotide 
probe is labeled, at the two ends, by a pair of chromophores that operate as donor and acceptor in a Förster 
resonant energy-transfer. The donor fluorescence is quenched with an efficiency that is strongly dependent on the 
donor-to-acceptor dist ance, hence on the configuration of the probe after hybridization with the DNA containing or 
not the selected allelic sequence. By time-correlated single-photon counting, performed with an 
excitation/detection system endowed with 30-ps resolution, we measure the time-resolved fluorescence decay of 
the donor and discriminate, by means of the decay-time value, the DNA bearing the allele conferring susceptibility 
to IDDM  from the DNAs bearing any other sequence in the same region of the DQB1 gene.  
 
3 
 
INTRODUCTION 
 
The human leukocyte antigen (HLA) system encodes highly polymorphic molecu les which are fundamental for the 
triggering of the immune response. Moreover, it is known that the expression of certain HLA molecules is  associated 
with the susceptibility to many autoimmune diseases , including insulin-dependent diabetes mellitus (IDDM) (1, 2).    
Distinguishing the subjects with susceptibility genes, before the onset of the disease, calls for the development of rapid 
high-throughput HLA typing technologies. On one hand, such an ambitious aim seems to contrast with the increasing 
number of susceptibility conferring alleles that are being discovered in patients affected by specific pathologies  (3). On  
the other hand, it is encouraging that a massively parallel sequencing technology has recently allowed mutation 
detection in picoliters of cancer specimens (4). For large-scale HLA analysis, we decided to set a method allowing the 
typing of genomic DNA simply purified from leukocytes without the need of polymerase chain reaction (PCR) 
amplification. We adopted a DNA probe matching the sequence of one of the most common alleles conferring 
susceptibility to IDDM in Caucasian population and, by making a novel use of Förster resonant energy transfer (FRET), 
we found a method for detecting sequence variations of even a single nucleotide in DNA template used as target. 
Markers of susceptibility to IDDM have been recognized in the HLA-II region and, in particular, in HLA-II DQA1 and 
DQB1 loci, coding for the  and  chains of DQ heterodimer, respectively (5). Extensive molecular studies of HLA-DQ 
genotype in patients with IDDM led to correlate the susceptibility with the polymorphism of a single aminoacid in both 
DQ and DQ chains (6, 7). In part icular, the combined presence of an arginine residue in position 52 of DQ chain  
and of a neutral residue (serine, alanine or valine) in position 57 of DQ chain is strongly associated with diabetes 
onset. On the contrary, the presence of aspartic acid at position 57 of DQ confers resistance to IDDM (2).  
In the present work we focussed on the typing of DQB1 locus by hybridizing target DNAs to a single probe 
corresponding to DQB1 0201 “susceptible” allele, which was dual labelled by a fluorescent reporter  in 5’ and a non-
fluorescing quencher in 3’. In such a probe, the fluorescence of the donor tetramethylrhodamine (TAMRA) is quenched 
via FRET by the black-hole quencher (BH2) depending on the conformational differences among the hybrids due to the 
probe/target mis matches. It is worth noting that fluorescence quenching by FRET is basic to many genotyping methods 
that include a step in which allele-specific hybridizat ion products must be recognized. These methods rely on the fact 
that FRET removes the excitation energy deposited on the donor (D) towards the acceptor (A) with an efficiency that 
depends on the D-to-A distance. As a result, when D and A are in close proximity, the D fluorescence is weaker than 
that emitted when they are at greater distances from each other. Multiple allele-specific probes, each labelled with a 
different D-A pair, can be used for querying allelic sequences (8). The sequence of each probe is complementary to a 
specific polymorphic sequence and probes are mixed all at once with the PCR-amplified template. The highly stringent 
hybridizat ion conditions allow annealing only of the perfectly matching probe, which results in a greater D-to-A  
distance, thus in an enhanced fluorescence emission of D. Conversely, as the non-matching probes preserve the native 
coiled conformation, their fluorescence is quenched. The genotype of the template DNA is inferred by assessing which 
D is the fluorescing one. We exploit the fact that FRET can produce quantitatively different fluorescence emissions 
depending on the probe-target hybrid conformation, thus making it feasible SNP genotyping by means of a single probe. 
Pioneering attempts in this direction have been made by Gaylord and collaborators (9) and, later, by Al Attar and 
collaborators (10). The latter group used a cationic polymer conjugated to the targets as D and monitored the 
fluorescence intensity of A attached to a single peptide nucleic acid probe. As the neutral peptide backbone of the probe 
did not bind to D, the acceptor A received the excitation energy only upon hybridizat ion of the probe to the targets. By 
applying this scheme to typing of ABL polymorphis m in the BCR-ABL oncogene, Al Attar et al. have determined 
significantly different values of the FRET efficiency between D and A when the probe was hybridized to each of t he 
possible target sequences (i.e. to each of the possible mutated alleles). Thus, they demonstrated the feasibility of ABL 
typing by using a single probe. It is easy to realize that distinguishing among the hybrids that our probe forms with the 
different allelic sequences by absolute measurements of D-fluorescence intensity is a hopeless approach to the 
development of a typing method suitable for non-amplified genomic DNA. Indeed, a high-throughput screening method 
based on FRET must work with cellular lysates, where the DNA concentration is variable from sample to sample , and 
utilize detectors whose response is stable against environmental stray light conditions . In our approach we quantify the 
FRET efficiencies of each probe/template hybrid by analyzing the D fluorescence temporal decay on a very fast time 
scale. We measure the TAMRA-fluorescence decay time (D) upon picosecond laser excitation, at a wavelength that is 
only absorbed by this chromophore, and detect the fluorescence by a time-correlated single-photon counting apparatus, 
which is endowed with a temporal resolution of <30 ps. Though the acquisition rate is less than one photon per 
excitation pulse, which ensures the applicability of our technique to the detection of even few probe -target duplexes, 
good determinations of the D values are done in few minutes due to the megahertz repetition rate of the excitation laser. 
The slight differences in the distance of the BHQ2 acceptor from the TAMRA donor and the consequent differences in 
FRET efficiencies produce distinct D values for the probe hybridized to each of the allelic sequences.  
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RESULTS 
 
Identification of allele-specific HLA-II DQB1 oligonucleotides  
In order to establish our FRET-based HLA-II DQB1 typing method we first set the system by using a panel of synthetic 
oligonucleotides listed in Fig. 1. These oligonucleotides are complementary to the coding sequences of the eight 
relevant DQB1 alleles and encompass codons 51 to 60 (6). Nucleotide variat ions with respect to the 0201 allele, shown 
on the top, are marked. Each oligonucleotide was hybridized with the probe corresponding to the 0201 variant having 
the GCC codon for alanine in position 57. The oligoprobe and the structures of the TAMRA donor and BHQ2 acceptor 
molecules are shown in Fig. 2. In general, to increase the specificity of a probe for its target DNA, it is desirable to 
design the oligonucleotide with a great rather than a small number of nucleotides. However, this is not true for probes 
dual-labeled at the 5’- and 3’-positions by a D and an A interacting by FRET, in that the D-to-A distance cannot 
remarkably overcome the Förster radius. We designed a probe of 22 nucleotides covering from codon 51 up to the first 
base of codon 58 as we preliminarily demonstrated
 
that probe/target mismatches next to the probe ends, where D or A  
are covalently bound, cause the greatest changes in the FRET efficiency  (11, 12). In the present case, mismatches at the 
polymorphic codon 57, which occur in the cases of all variants except 0201 and 0302 , are expected to prevent pairing of 
the last three-four bases on the side of the BHQ2. Such an “unzipping” of the duplex structure should let A approach D 
and cause a sizeable decrease in the donor-fluorescence decay time (D). It is worth noting that the eight DQB1 alleles 
are all identical from codon 58 to codon 60, thus further extending the probe would prevent unzipping.   
The D values that we determined for the DQB1 0201 probe binding to each of the eight synthetic 
oligonucleotides are listed in column a) of Table 1. For all hybrids, except those that the probe forms with the variant 
sequences 05031 and 0602, we find significantly different D values. Most importantly, the greatest value corresponds 
to the perfect matching of the probe with the oligonucleotide having the sequence of the DQB1-0201 allele. The next  
highest D value is exhib ited by the probe binding the 0302 sequence, which is the only one displaying a base 
composition identical to that of the 0201 allele at codon 57.  
The manner in which the other values of D scale agrees with what we previously observed by using a probe 
containing 18 instead of 22 nucleotides (12). Moreover, as the 18-nucleotide probe did not cover codon 51, which is 
identical in all allelic variants, the unzipping of the 5’-end observed for the 18-nucleotides probe does not occur here. 
Thus, as shown in Table 1, for the mis matching oligonucleotides mimicking the sequences of the DQB1 allelic variants 
of other than 0201, we measure D values that are both greater than those for the 18-nucleotide probe (see the cases of 
alleles 0501, 0502, 05031, and 0602, which produced very fast decays when hybridized to the 18-nucleotide probe) and 
much more similar to that measured for the perfectly matching target oligonucleotide.  
 
For these target sequences we had hypothesized an unzipping including the first 5 nucleotides, due to the 
double mismatch of the second and fifth nucleotides. However, addit ion of the three nucleotides corresponding to codon 
51 confers a greatly enhanced selectivity to the 22-nucleotide probe and does not prevent discrimination of the DQB1-
0201 genotype. Beside the above considerations, the scaling of the values in column a) of Table 1 agrees with the 
explanations that we presented in the quoted work of the dependence of the D changes on both number and position of 
the base mismatches (12). Moreover, the data obtained in the present work with the 22-nucleotides probe, which we 
deemed ideal for typing of genomic DNA templates, confirm that the type of mismatch can also influence the decay 
time. In fact, the 0501 and 0602 alleles, having only one nucleotidic variation in the same position of codon 57 (CAA 
and CTA, respectively) d isplay significantly different D values when hybridized to the 0201 probe.  
 
HLA-II DQB1 typing of non-amplified genomic DNA 
In order to validate our FRET-based HLA-II DQB1 typing approach set with synthetic oligonucleotides, we tested the 
system with non PCR-amplified genomic DNAs. DNA was extracted from five HLA -homozygous lymphoblastoid cell 
lines having the following DQB1 specificit ies: PITOUT (0201); HOM-2 (0501); JVM (0301); WT51 (0302); OLL 
(0402) (6). Purified double-stranded DNA was denatured by heating and then hybridized to the dual-labeled DQB1 
0201 probe at a specific annealing temperature as indicated in Methods. Upon suitable modifications of the setup as to 
the excitation/collect ion optics, the corresponding D values were measured (column b of Table 1). These values are 
surprisingly equal to those obtained with the oligonucleotides corresponding to the same DQB1 allele, which are listed 
on the same lines in co lumn a), in spite of the fact that these measurements were performed on entire genomic DNA .  
 
 
DISCUSSION  
 
In this study we successfully developed a new method to identify the DQB1-0201 variant, an alle le that is statistically  
over-represented in patients with insulin-dependent diabetes mellitus (type-1 diabetes). Indeed this allele is considered a 
susceptibility marker for people predisposed to type-1 diabetes. The method is based on measurements of fluorescence 
decay times performed with single photon sensitivity and picosecond resolution. Purified, non-amplified genomic 
DNAs bearing different sequences in the polymorphic region of the HLA-DQB1 gene were hybridized with a single 
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DNA probe corresponding to the DQB1-0201 allele. The probe was dual-labelled with fluorescence donor-and-acceptor 
chromophores at its opposite ends. The chromophores undergo FRET, whose efficiency is characterized by measuring 
the fluorescence decay time D of the donor. As the FRET efficiency, and hence the D value, is differently modified by 
the number of probe-to-target mismatches and by their positions, the hybrids formed by the probe with each allelic 
variant are identified by distinct values of D. It is worth noting that the picosecond-laser excitation wavelength we 
adopted, 532 nm, is very close to the absorption peak of the TAMRA donor, which falls at 556 nm, being not even 
absorbed by the non-fluorescent BHQ2 acceptor.  
To determine the values of D we devised suitable strategies for taking into account that, though the excitation  
pulses are only absorbed by TAMRA, not all the TAMRA molecules that contribute to the detected fluorescence -decay 
patterns undergo FRET and decay with time-constant D. In both oligonucleotide and DNA samples, there can be  dual-
labelled fluorescent probes left free in solution, thus keeping their natural conformation as single-stranded probe and 
contributing decay-components shorter than D. There might also be probes lacking the BHQ2 acceptor as well as 
TAMRA molecules not bound to the probe: both of them decay slower than any TAMRA quenched via FRET by the 
presence of a more-or-less distant BHQ2. The overall effect is that the rough experimental decay patterns deviate from 
single exponentials. In the case of oligonucleotides the decays contain fast transients of negligible amplitude, which  
become irrelevant after <800 ps from the peak of the fluorescence signals. This fact not only allows a simple analysis of 
the experimental decays, but also reveals the almost complete annealing of the dual-labelled probe molecules to the 
target oligonucleotides. In the case of DNAs the probe binding to the target sequences is contrasted by the presence in 
solution of the complementary sequences and by partial annealing to genomic DNA regions other than the allelic -
variant under examination. However, a  neutral application to all experimental decay patterns of the strategy described in 
Methods and already used in a previous work of ours (12), brought to decays (Dxxx) of remarkable amplitudes that could 
be fitted by the sum of two exponentials. The faster one has a decay time τ’ = 709 ± 67 ps and is attributed to the 
partially annealed probes, while the slower one decays with the D values reported in Table 1.  
The HLA typing method reported is relatively simple; the instrumentation that is needed is not particularly  
expensive and is prone to be adapted for routine use in a diagnostic laboratory. The great advantage of processing very 
quickly a considerable number of samples and the high specificity of the detection may allow the use of this method not 
only for routine typing of HLA, but also for the typing of specific “pathologic” sequences, for example of mutated 
oncogenes, in order to identify the specific mutation in tumor tissues and most importantly the extent of mutated genes 
in pre-neoplastic lesions. 
 
 
METHODS 
 
Hybridization of oligonucleotides. The D-A pair in the s ing le-st randed dual-labelled o ligonucleot ide probe, 
D-5’(ACGCTGCTGGGGCTGCCT GCCG)3’-A , was the tet ramethy lrhodamine analogue 5'-Dimethoxytrity loxy -
5-[N-((tetramethy lrhodaminyl)-aminohexyl)-3-acry limido]-2’-deoxyUrid ine-3’-[(2-cyanoethyl)-(N,N-
diisopropyl)]-phosphoramid ite (TAMRA) and the black hole quencher 4' -(4-Nit ro-phenyld iazo)-2'-methoxy-5'-
methoxy-azobenzene-4''-(N-ethy l)-N-ethy l-2-cyanoethy l-(N,N-d iisopropyl)-phosphoramid ite (BHQ2). The dual-
labeled  probe, purified by HPLC and the oligonucleotides were purchased from TIB Molbiol (Genova, Italy). The 
lyophilized samples, each one in an amount of about 20 nM, were diluted in Tris -HCl/EDTA buffer (pH 7.6; 10 mM 
ionic strength) down to concentration values that were determined spectrophotometrically  from UV absorbance spectra 
over 1-cm pathway. The probe and each target oligonucleotide were diluted to the same final concentration and mixed  
in equal volumes (final concentration: 250 nM). The mixtures were gradually heated at a rate of +3 ºC/min to 98 °C and 
kept at this temperature for 10 min to allow for the denaturation of secondary structures of the single strands and to 
destroy the dimers that could be present. The solutions were then cooled down, at a rate of 1 ºC/min, to a plateau 
temperature of 73 ºC, which is lower by 1 °C than the melt ing temperature of the hybrids. The samples were kept at the 
plateau temperature for 20 min, in order to maximize annealing. It is worth noting that the hybrid melt ing temperatures 
are different for hybrids formed by the dual-labeled probe with the different oligonucleotides : the value is 74 ºC for the 
DQB1-0201 o ligonucleotide (TIB Molb iol, private communication) but, for the other hybrids, it is lower due to the base 
mis matches. In an attempt to favor the probe annealing also to the other oligonucleotides , we adopted a plateau 
temperature of 67 ºC in the case of 0302 (two base mis matches), 64 ºC in the case of 0301 (three base mis matches), 61 
ºC in the cases of 05031 and 0402 (four base mismatches), 58 ºC for 0501, 0502 and 0602. In  practice, starting from the 
73 ºC value used as the plateau temperature for the probe annealing to the perfectly matching 0201 variant, we adopted 
values three degrees lower for every additional mis match. Finally the hybridized solutions were slowly brought to room 
temperature (2 ºC/min) to be measured with the TCSPC apparatus. The whole procedure of temperature -controlled  
annealing was carried out in the thermostat of a ThermoQuest-Finnigan gas chromatograph (San Jose, CA, US).  
 
Hybridization of genomic DNA. Five lymphoblastoid cell lines, HLA homozygous  (13), were used to extract genomic  
DNA by standard procedures. The procedure of temperature-controlled annealing performed after DNA denaturation at 
98 °C was similar to that adopted for oligonucleotides, except for the fact that the five samples were put together in the 
thermostat and exposed to a sequence of five 20-min periods in which the plateau temperatures were set, in order, at the 
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values 73 ºC, 67 ºC, 64 ºC, 61 ºC, and 58 ºC. These decreasing temperature values should allow optimal annealing of 
the probe to the DQB1 antisense alleles in the fo llowing order: 0201 first, then 0302, 0301, 0402, and 0501 at last. 
 
Measurements of D-fluorescence decay time. A ll TCSPC measurements were performed at room temperatu re. In  
the case of o ligonucleot ides the fluorescence was detected at 90 deg with respect to laser excitat ion and the 
sample was contained in 1 cm × 1 cm quartz cuvette with four po lished windows. In the case of DNAs, due the 
smallness of the available sample vo lumes, we adopted an ep i-fluorescence 20× microscope geometry in which  
the wells contain ing 200 l o f the samples were excited  and the fluorescence co llected  along the same d irect ion . 
The D-fluorescence was separated from the reflected/back-scattered excitat ion by a dichro ic mirro r at 45 deg  
(DMLP567, Thorlabs GmbH, Dachau , Germany). The excitat ion/detect ion apparatus, extensively described in a 
prev ious work of ours  (12) , is entirely made up of commercial components. Its main featu res are: excitat ion pu lses 
at 532 nm (6.4 ps durat ion at 113 MHz repet it ion rate) , typ ically attenuated by a facto r >10
3
 to ach ieve sing le -
photon regime in the fluorescence detect ion; sing le-photon avalanche diode with bu ilt-in act ive quench ing  
circu it ry and thermoelect ric coo ling  as the detector;  fluorescence decay patterns recorded with 2.44 ps/channel 
resolut ion; fu ll-width at half-maximum durat ion o f the detected excitat ion pu lse of <30 ps; time-to -amplitude 
conversion  operated in reversed start-stop modality so that each detected photon produced  a valid  start s ignal;  
fluorescence detected above 550 nm;  each  decay  pattern acqu ired  up to a fixed number o f counts at the peak, 
namely 65535; each acqu is it ion time recorded; each measurement repeated three t imes  at least. The zero o f the 
time scale was set at the peak channel fo r all decay patterns.   
In add it ion to the measurements on the hybrids, we also measured the fluorescence decay of a solut ion o f 
the pure single-st randed probe at the same concentrat ion as in the hybrid ized samples. Preliminarly to data 
analys is, the rough decay patterns acqu ired for both th is solut ion and those contain ing the hybrid ized  
oligonucleot ides were normalized to the acqu isit ion t ime and to the absorbance values at 556 nm (TAMRA peak).  
The rough decay data were treated as described  below.  
 
Data analysis for τD determinat ion: oligonucleotides. All decay patterns exh ib it fast in it ial t rans ients of 
neglig ib le amplitudes, thus showing  that dual-labelled  fluorescent p robes left free in so lut ion are v irtually absent  
in our o ligonucleot ide samples. Such a fast transient represents the majority o f the fluorescence decay of the 
solution o f the pure s ing le-st randed probe, in which it is summed to the slow decay component emitted by free 
TAMRA. Thus, after normalizing to acquis it ion time and TAMRA absorbance, we subtract this slow component  
(with the amplitude and lifet ime detected fo r the pure sing le -stranded probe, see below) from all decays and fit the 
difference start ing  from 400 to 800 ps after the  peak. For all hybrid ized o ligonucleot ide samples we find very  
good fitt ings by using sing le exponent ials whose t ime constants we interpret  as the τD values (see first co lumn in  
Table 1). As an example we show the case of the oligonucleotide mimicking  the DQB1-0201 in Fig . 3.  
 
Data analysis for τD determination: DNAs. We apply a modified version of the p rocedure described in  a prev ious 
work of ours  (12) . As in all measured decays patterns, preliminarly normalized to acqu isit ion t ime and TAMRA 
absorbance, we recognize a slow decay component typ ical of not-quenched TAMRA, either free in solut ion o r 
bound to hybridized probes lacking the BHQ2 acceptor, we beg in by subtracting th is component from the rough  
experimental decays of all the hybridized DNA samples with the init ial amplitude and lifet ime that we detected in  
the decay pattern measured on the so lut ion of pure p robe . The resu lt ing patterns are normalized to their integrals. 
Let us call these normalized decay patterns F201, F501, …, short ly Fxxx. The subtract ion is performed a lso on the 
probe decay pattern, which is then normalized to its integral to obtain FPROBE. We then observe that FPROBE is well 
fitted by  a three-exponent ial decay  
 
YPROBE (t) = A1P  exptτ1P + A2P  exptτ2P + A3P  exptτ3P       (1) 
 
The best procedu re we found to get rid o f the FPROBE contribut ions in the decays F201, F501, F301, F302, and F402, of 
the samples contain ing the DNAs was as fo llows: we carry out mult i-exponent ial fits of the latter decays from 
which we only extract the values A1xxx, A2xxx, and A3xxx of the three fastest components and use them to perform 
the fo llowing  weighted subtract ions 
 
Fxxx A1xxx+ A2 xxx+ A3xxxA1P+ A2P+ A3P FPROBE ≡ Dxxx       (2) 
that yield the final curves D201, D501, D301, D302, and D402. Curves Dxxx  should only contain the fluorescence arising 
from the desired double-stranded fraction of each sample with decay time τD and from the probe molecules partially  
annealed to other regions of the genomic DNA target. Actually, all curves Dxxx  had dynamic ranges covering more than 
one decade and exh ibited bi-exponential decays starting from ~500 ps after the peak. Best fits of the Dxxx  curves 
provide the values of the corresponding decay times ’ and  D. The whole procedure is illustrated in Fig. 4 for the DNA 
of the cell line homozygous for the DQB1-0201 allelic variant. 
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Figure 1  
Sequenc es (antisense) of the region comprising codons 51 to 60 of the eight relevant DQB1 allelic variants (listed on 
the left). Nucleotide changes with respect to DQB1-0201, are marked. The regions shaded in grey are those not 
covered by the oligonucleotide used as a probe (see Fig. 2). 
 
 
 
Figure 2  
FRET probe matching the DQB1-0201 sequence between codons 51 and 58 (22 bases) and carrying the TAMRA donor  
and the BHQ2 quencher, whose structures are shown in the bottom.  
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Figure 3  
Fluorescence decay of the TAMRA donor of the probe bound to the oligonucleotide mimicking the sequence of the 
DQB1-0201 allele. Grey dots: experimental data after subtraction of the slow decay of TAMRA molecul es left free in 
solution. Black line: fitting curve with best-fitting parameters D = 2722.61 ps and 652.3 counts as the background. 
Open dots: residuals.  
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a) 
 
 
b) 
 
 
c) 
 
 
Figure 4  
Data analysis procedure: a) Rough experimental decay patterns of the samples containing: (black dots) the hybridized 
DNA bearing DQB1-0201 allelic variant; (open dots) the dual -labelled probe only. b) Integral-normalized fluorescence 
decays F201 (black dots) and FPROBE (open dots) as obtained from the decays in a) upon subtraction of the slow decay 
component of not-quenched TAMRA. Black line: fitting curve YPROBE in eq. (1). Inset: residuals of this fit plotted on the 
same vertical scale as in the main panel. c) Decay D201 (grey dots) as obtained by applying eq. (2) to the data in b). 
Black line: bi-exponential fit with best-fitting parameters τ’ = 709.92 ps and D = 2724.43 ps. Open dots: residuals. The 
arbitrary units in b) and c) are identical to allow the comparison, in amplitude, of D201 to F201 (see Discussion).  
 
11 
 
 
 
Table 1  Values of the TAMRA-donor fluorescence decay time, D ± standard deviation, for the 22-base long 
dual-labelled DQB1 0201 probe (see Fig. 2) bound to: a) synthetic oligonucleotides corresponding to the region 
between codons 51 and 58 of the listed all elic variants (see Fig. 1); b) purified DNAs extracted from HLA-homozygous  
lymphoblastoid cell  lines. NA: sample not available.   
 
 
DQB1- allelic variant 
a) oligonucleotides 
D ± SD (ps)  
b) DNAs 
D ± SD (ps)  
0201 2725 ± 3 2723 ± 3 
0501 2514 ± 3 2512 ± 5 
0502 2404 ± 11 N.A. 
05031 2427 ± 2 N.A. 
0602 2430 ± 9 N.A. 
0301 2481 ± 3 2479 ± 3 
0302 2599 ± 3 2603 ± 5 
0402 2462 ± 3 2466 ± 5 
 
 
 
